Does Dr. HODA ABDEL SALAM have financial conflicts of interest?

Dr. HODA ABDEL SALAM (M.D.) has received a total of $310 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $310 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. HODA ABDEL SALAM?

According to CMS Open Payments data, Dr. HODA ABDEL SALAM received funding from ABBOTT LABORATORIES ($135), NOVARTIS PHARMACEUTICALS CORPORATION ($53), and ABBVIE ($45).

Does Dr. HODA ABDEL SALAM receive research grants or speaking fees?

Dr. HODA ABDEL SALAM has received $310 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. HODA ABDEL SALAM

M.D.Real-Time Hydrated

Specialty: Internal Medicine

Practice Location: NEW BRITAIN, CT 06051

NPI Number: 1144509316

LIFETIME INDUSTRY VALUE

$310

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ABDEL SALAM is a verified Internal Medicine practitioner based in NEW BRITAIN, CT.

Between 2021 and 2024, Dr. ABDEL SALAM had an overall industry promotional and research financial footprint of $310 as recorded in the federal CMS Open Payments database.

$310 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABDEL SALAM's primary funding source is ABBOTT LABORATORIES, which accounts for $135 (representing 43.6% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ABBOTT LABORATORIES

Rank 1

$135

43.6%

NOVARTIS PHARMACEUTICALS CORPORATION

Rank 2

$53

17.2%

ABBVIE

Rank 3

$45

14.6%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.